Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Entrada Therapeutics (TRDA) Tax Rate (2023 - 2025)

Entrada Therapeutics has reported Tax Rate over the past 3 years, most recently at 0.17% for Q4 2025.

  • Quarterly results put Tax Rate at 0.17% for Q4 2025, down 24879.0% from a year ago — trailing twelve months through Dec 2025 was 0.68% (down 201.0% YoY), and the annual figure for FY2025 was 0.63%, down 198.0%.
  • Tax Rate for Q4 2025 was 0.17% at Entrada Therapeutics, up from 1.61% in the prior quarter.
  • Over the last five years, Tax Rate for TRDA hit a ceiling of 248.62% in Q4 2024 and a floor of 114.23% in Q2 2023.
  • Median Tax Rate over the past 3 years was 0.17% (2025), compared with a mean of 13.62%.
  • Biggest five-year swings in Tax Rate: surged 12093bps in 2024 and later tumbled -24879bps in 2025.
  • Entrada Therapeutics' Tax Rate stood at 203.77% in 2023, then increased by 22bps to 248.62% in 2024, then tumbled by -100bps to 0.17% in 2025.
  • The last three reported values for Tax Rate were 0.17% (Q4 2025), 1.61% (Q3 2025), and 0.47% (Q2 2025) per Business Quant data.